IMX is trading at $0.125231, up 4.69% over 24 hours, and sits near the top of its $0.116442–$0.126363 daily range. The price is about 0.9% below the daily high, indicating a strong intraday recovery, though one day’s move alone does not establish a sustained trend.

All five supplied hourly moving averages cluster between $0.1199 and $0.1207, with the current price roughly 3.7%–4.5% above them. This is a supportive short-term signal, but the averages are all hourly measures and therefore provide limited evidence about the broader trend.

The 1-hour RSI of 59 and 7-day RSI of 53 indicate positive-to-neutral momentum rather than an extreme reading. These values leave room for further short-term gains, but they do not independently confirm a durable breakout.

Momentum is mixed across time periods: IMX is up 2.60% over seven days, yet down 8.96% over 14 days and 37.15% over 30 days. The recent gains therefore look more like a short-term rebound within a substantially weaker month-long performance than clear evidence that the broader decline has reversed.

Reported 24-hour volume is 7,884,759, and volume is 6.96% of market capitalization. Without a comparison to prior volume, this cannot establish whether participation is increasing or unusually strong; it offers context but little independent direction for the rating.

IMX remains about 98.7% below its $9.52 all-time high, reached in November 2021, which underscores the scale of its long-term loss but does not by itself predict near-term price action. The evidence supports a Hold: the daily rise, price above the hourly averages, and non-extreme RSI readings are constructive, while the steep 30-day decline and negative 14-day return argue against treating the bounce as a confirmed reversal.

The primary evidence for Hold is the conflict between improving short-term conditions and still-weak medium-term momentum. A Buy would require stronger evidence that the rebound is persisting beyond the latest week, while the positive daily move and supportive hourly readings make a Sell less compelling on the supplied data.